Voyager Therapeutics
VYGR
53 hedge funds and large institutions have $128M invested in Voyager Therapeutics in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
10% more funds holding
Funds holding: 48 → 53 (+5)
10% more capital invested
Capital invested by funds: $116M → $128M (+$11.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Partner Investment Management
San Francisco,
California
|
+$1.84M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.35M |
| 3 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$1.23M |
| 4 |
AC
Ascend Capital
Orinda,
California
|
+$789K |
| 5 |
GC
Globeflex Capital
San Diego,
California
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$2.89M |
| 2 |
Goldman Sachs
New York
|
-$1.28M |
| 3 |
JP Morgan Chase
New York
|
-$1.05M |
| 4 |
CC
Casdin Capital
New York
|
-$623K |
| 5 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$383K |
VYGR Hedge Fund Activity: Q3 2016 in Review
53 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2016, worth a combined $128M — up 9.7% from $116M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VYGR positions and 6 closed out — a net gain of 5 holders — while 20 added to existing stakes and 11 trimmed.
The largest buyer was Partner Investment Management, adding an estimated $1.84M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $2.89M sold.
- 53 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2016, up from 48 in Q2 2016.
- Funds reported $128M of Voyager Therapeutics stock for Q3 2016, up 9.7% quarter-over-quarter.
- 11 funds opened new Voyager Therapeutics positions in Q3 2016 and 6 closed out, a net change of +5 holders.
- The largest Voyager Therapeutics buyer in Q3 2016 was Partner Investment Management, an estimated $1.84M added.
- The largest Voyager Therapeutics seller in Q3 2016 was Janus Henderson Investors US, an estimated $2.89M sold.
Based on aggregated 13F filings for Q3 2016.